| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |